These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21387762)

  • 1. [Pathophysiology of overactive bladder].
    Juszczak K; Wyczółkowski M; Thor PJ
    Przegl Lek; 2010; 67(7):488-90. PubMed ID: 21387762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of overactive bladder.
    Chu FM; Dmochowski R
    Am J Med; 2006 Mar; 119(3 Suppl 1):3-8. PubMed ID: 16483862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder.
    Latini JM; Giannantoni A
    Expert Opin Pharmacother; 2011 May; 12(7):1017-27. PubMed ID: 21473706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic organ prolapse and overactive bladder.
    de Boer TA; Salvatore S; Cardozo L; Chapple C; Kelleher C; van Kerrebroeck P; Kirby MG; Koelbl H; Espuna-Pons M; Milsom I; Tubaro A; Wagg A; Vierhout ME
    Neurourol Urodyn; 2010; 29(1):30-9. PubMed ID: 20025017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
    Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
    Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urgency assessment in the evaluation of overactive bladder (OAB).
    Starkman JS; Dmochowski RR
    Neurourol Urodyn; 2008; 27(1):13-21. PubMed ID: 17671973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder.
    Chapple CR; Roehrborn CG
    Eur Urol; 2006 Apr; 49(4):651-8. PubMed ID: 16530611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models in overactive bladder research.
    Parsons BA; Drake MJ
    Handb Exp Pharmacol; 2011; (202):15-43. PubMed ID: 21290220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pathophysiology underlying overactive bladder syndrome possibly due to benign prostatic hyperplasia].
    Akino H; Maegawa M; Nagase K; Tanaka I; Nakai M; Ishida Y; Oyama N; Miwa Y; Yokoyama O
    Hinyokika Kiyo; 2008 Jun; 54(6):449-52. PubMed ID: 18634444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention.
    Liu HT; Kuo HC
    Neurourol Urodyn; 2009; 28(1):78-81. PubMed ID: 19089891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower urinary tract symptoms (LUTS) and bladder afferent activity.
    Yoshimura N
    Neurourol Urodyn; 2007 Oct; 26(6 Suppl):908-13. PubMed ID: 17654565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder.
    Andersson KE; Gratzke C; Hedlund P
    BJU Int; 2010 Oct; 106(8):1114-27. PubMed ID: 21156013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overactive bladder: Is there a link to the metabolic syndrome in men?
    Kirby MG; Wagg A; Cardozo L; Chapple C; Castro-Diaz D; de Ridder D; Espuna-Pons M; Haab F; Kelleher C; Kölbl H; Milsom I; Van Kerrebroeck P; Vierhout M; Salvatore S; Tubaro A
    Neurourol Urodyn; 2010 Nov; 29(8):1360-4. PubMed ID: 20589717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
    Liu HT; Kuo HC
    Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LUTS and OAB in men: gender matters.
    Muller N
    Ostomy Wound Manage; 2011 Mar; 57(3):16-7. PubMed ID: 21721288
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychometric validation of the overactive bladder satisfaction with treatment questionnaire (OAB-SAT-q).
    Margolis MK; Fox KM; Cerulli A; Ariely R; Kahler KH; Coyne KS
    Neurourol Urodyn; 2009; 28(5):416-22. PubMed ID: 19030182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is overactive bladder in children and adults the same condition? ICI-RS 2011.
    Salvatore S; Serati M; Origoni M; Candiani M
    Neurourol Urodyn; 2012 Mar; 31(3):349-51. PubMed ID: 22422704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.